Source: Annual Congress 2006 - Screening, diagnosis, staging, prognosis, biological features
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
I. M. Kuznetsov, O. B. Ilina, G. S. Zubov, S. A. Shalaev, L. N. Bisenkov (St. Petersburg, Russian Federation). The invasive diagnostics of lung cancer with secondary inflammatory changes. Eur Respir J 2006; 28: Suppl. 50, 559

Member's Comments

No comment yet.

Related content which might interest you: The clinicofunctional features of patients with lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006 The terms of adaptation of functional systems of patients with lung cancer and secondary inflammatory changes after surgical treatment Source: Eur Respir J 2006; 28: Suppl. 50, 750s Year: 2006 The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006 The primary prevention of lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Markers of angiogenesis in serum are correlating with disease progress in lung cancer Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001 Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020 Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002 Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 The clinical value of autoflurescence bronchoscopy for precancerous lesions in operable primary lung cancer patients Source: Annual Congress 2007 - Diagnostic bronchoscopy and transthoracic aspiration Year: 2007 The relationship between hemoptysis and the features of tumors in primary lung cancer Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007 Dealys in the diagnosis and treatment of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Modern profiling of advanced lung cancer at the primary diagnosis and during therapy Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018